Global Basal Insulin (Long-Acting Insulin) Market Insights, Forecast to 2028

Global Basal Insulin (Long-Acting Insulin) Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Basal Insulin (Long-Acting Insulin) Product Introduction
1.2 Market by Type
1.2.1 Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Market by Application
1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Basal Insulin (Long-Acting Insulin) Sales Estimates and Forecasts 2017-2028
2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Estimates and Forecasts 2017-2028
2.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Basal Insulin (Long-Acting Insulin) Sales by Region
2.4.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022)
2.4.2 Global Sales Basal Insulin (Long-Acting Insulin) by Region (2023-2028)
2.5 Global Basal Insulin (Long-Acting Insulin) Revenue by Region
2.5.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022)
2.5.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers
3.1.1 Global Top Basal Insulin (Long-Acting Insulin) Manufacturers by Sales (2017-2022)
3.1.2 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Basal Insulin (Long-Acting Insulin) in 2021
3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers
3.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (2017-2022)
3.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Basal Insulin (Long-Acting Insulin) Revenue in 2021
3.3 Global Basal Insulin (Long-Acting Insulin) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Basal Insulin (Long-Acting Insulin) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type
4.1.1 Global Basal Insulin (Long-Acting Insulin) Historical Sales by Type (2017-2022)
4.1.2 Global Basal Insulin (Long-Acting Insulin) Forecasted Sales by Type (2023-2028)
4.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
4.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type
4.2.1 Global Basal Insulin (Long-Acting Insulin) Historical Revenue by Type (2017-2022)
4.2.2 Global Basal Insulin (Long-Acting Insulin) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)
4.3 Global Basal Insulin (Long-Acting Insulin) Price by Type
4.3.1 Global Basal Insulin (Long-Acting Insulin) Price by Type (2017-2022)
4.3.2 Global Basal Insulin (Long-Acting Insulin) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application
5.1.1 Global Basal Insulin (Long-Acting Insulin) Historical Sales by Application (2017-2022)
5.1.2 Global Basal Insulin (Long-Acting Insulin) Forecasted Sales by Application (2023-2028)
5.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application
5.2.1 Global Basal Insulin (Long-Acting Insulin) Historical Revenue by Application (2017-2022)
5.2.2 Global Basal Insulin (Long-Acting Insulin) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Application
5.3.1 Global Basal Insulin (Long-Acting Insulin) Price by Application (2017-2022)
5.3.2 Global Basal Insulin (Long-Acting Insulin) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Basal Insulin (Long-Acting Insulin) Market Size by Type
6.1.1 North America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
6.1.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)
6.2 North America Basal Insulin (Long-Acting Insulin) Market Size by Application
6.2.1 North America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
6.2.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)
6.3 North America Basal Insulin (Long-Acting Insulin) Market Size by Country
6.3.1 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)
6.3.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Basal Insulin (Long-Acting Insulin) Market Size by Type
7.1.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
7.1.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)
7.2 Europe Basal Insulin (Long-Acting Insulin) Market Size by Application
7.2.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
7.2.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)
7.3 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country
7.3.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)
7.3.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Type
8.1.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
8.1.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)
8.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Application
8.2.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
8.2.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)
8.3 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Region
8.3.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2028)
8.3.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Type
9.1.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
9.1.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)
9.2 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Application
9.2.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
9.2.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)
9.3 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Country
9.3.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)
9.3.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Type
10.1.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)
10.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Application
10.2.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)
10.3 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Country
10.3.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi Aventis
11.2.1 Sanofi Aventis Corporation Information
11.2.2 Sanofi Aventis Overview
11.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Aventis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Biocon
11.4.1 Biocon Corporation Information
11.4.2 Biocon Overview
11.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biocon Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biocon Recent Developments
11.5 Julphar
11.5.1 Julphar Corporation Information
11.5.2 Julphar Overview
11.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Julphar Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Julphar Recent Developments
11.6 Exir
11.6.1 Exir Corporation Information
11.6.2 Exir Overview
11.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Exir Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Exir Recent Developments
11.7 Sedico
11.7.1 Sedico Corporation Information
11.7.2 Sedico Overview
11.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sedico Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sedico Recent Developments
11.8 Wockhardt
11.8.1 Wockhardt Corporation Information
11.8.2 Wockhardt Overview
11.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wockhardt Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Basal Insulin (Long-Acting Insulin) Industry Chain Analysis
12.2 Basal Insulin (Long-Acting Insulin) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Basal Insulin (Long-Acting Insulin) Production Mode & Process
12.4 Basal Insulin (Long-Acting Insulin) Sales and Marketing
12.4.1 Basal Insulin (Long-Acting Insulin) Sales Channels
12.4.2 Basal Insulin (Long-Acting Insulin) Distributors
12.5 Basal Insulin (Long-Acting Insulin) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Basal Insulin (Long-Acting Insulin) Industry Trends
13.2 Basal Insulin (Long-Acting Insulin) Market Drivers
13.3 Basal Insulin (Long-Acting Insulin) Market Challenges
13.4 Basal Insulin (Long-Acting Insulin) Market Restraints
14 Key Findings in The Global Basal Insulin (Long-Acting Insulin) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Lantus
Table 3. Major Manufacturers of Levemir
Table 4. Major Manufacturers of Tresiba
Table 5. Major Manufacturers of Toujeo
Table 6. Major Manufacturers of Basaglar
Table 7. Major Manufacturers of Biosimilar Glargines
Table 8. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)
Table 11. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2022)
Table 12. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2023-2028) & (K Units)
Table 13. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2023-2028)
Table 14. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2017-2022)
Table 16. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2023-2028)
Table 18. Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers (2017-2022)
Table 20. Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2017-2022)
Table 22. Basal Insulin (Long-Acting Insulin) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 23. Global Basal Insulin (Long-Acting Insulin) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2021)
Table 25. Basal Insulin (Long-Acting Insulin) Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Basal Insulin (Long-Acting Insulin) Product Offered
Table 27. Date of Manufacturers Enter into Basal Insulin (Long-Acting Insulin) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 30. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 31. Global Basal Insulin (Long-Acting Insulin) Sales Share by Type (2017-2022)
Table 32. Global Basal Insulin (Long-Acting Insulin) Sales Share by Type (2023-2028)
Table 33. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2017-2022)
Table 36. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2023-2028)
Table 37. Basal Insulin (Long-Acting Insulin) Price by Type (2017-2022) & (US$/Unit)
Table 38. Global Basal Insulin (Long-Acting Insulin) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 39. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 40. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 41. Global Basal Insulin (Long-Acting Insulin) Sales Share by Application (2017-2022)
Table 42. Global Basal Insulin (Long-Acting Insulin) Sales Share by Application (2023-2028)
Table 43. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2017-2022)
Table 46. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2023-2028)
Table 47. Basal Insulin (Long-Acting Insulin) Price by Application (2017-2022) & (US$/Unit)
Table 48. Global Basal Insulin (Long-Acting Insulin) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 49. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 50. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 51. North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 54. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 55. North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)
Table 58. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)
Table 59. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 62. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 63. Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 66. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 67. Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)
Table 70. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)
Table 71. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)
Table 109. Novo Nordisk Corporation Information
Table 110. Novo Nordisk Description and Major Businesses
Table 111. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Novo Nordisk Recent Developments
Table 114. Sanofi Aventis Corporation Information
Table 115. Sanofi Aventis Description and Major Businesses
Table 116. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Sanofi Aventis Recent Developments
Table 119. Eli Lilly Corporation Information
Table 120. Eli Lilly Description and Major Businesses
Table 121. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Eli Lilly Recent Developments
Table 124. Biocon Corporation Information
Table 125. Biocon Description and Major Businesses
Table 126. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Biocon Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Biocon Recent Developments
Table 129. Julphar Corporation Information
Table 130. Julphar Description and Major Businesses
Table 131. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Julphar Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Julphar Recent Developments
Table 134. Exir Corporation Information
Table 135. Exir Description and Major Businesses
Table 136. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Exir Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Exir Recent Developments
Table 139. Sedico Corporation Information
Table 140. Sedico Description and Major Businesses
Table 141. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Sedico Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Sedico Recent Developments
Table 144. Wockhardt Corporation Information
Table 145. Wockhardt Description and Major Businesses
Table 146. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Wockhardt Basal Insulin (Long-Acting Insulin) Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Wockhardt Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Basal Insulin (Long-Acting Insulin) Distributors List
Table 152. Basal Insulin (Long-Acting Insulin) Customers List
Table 153. Basal Insulin (Long-Acting Insulin) Market Trends
Table 154. Basal Insulin (Long-Acting Insulin) Market Drivers
Table 155. Basal Insulin (Long-Acting Insulin) Market Challenges
Table 156. Basal Insulin (Long-Acting Insulin) Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Basal Insulin (Long-Acting Insulin) Product Picture
Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Share by Type in 2021 & 2028
Figure 3. Lantus Product Picture
Figure 4. Levemir Product Picture
Figure 5. Tresiba Product Picture
Figure 6. Toujeo Product Picture
Figure 7. Basaglar Product Picture
Figure 8. Biosimilar Glargines Product Picture
Figure 9. Global Basal Insulin (Long-Acting Insulin) Market Share by Application in 2021 & 2028
Figure 10. Type 1 Diabetes
Figure 11. Type 2 Diabetes
Figure 12. Basal Insulin (Long-Acting Insulin) Report Years Considered
Figure 13. Global Basal Insulin (Long-Acting Insulin) Sales 2017-2028 (K Units)
Figure 14. Global Basal Insulin (Long-Acting Insulin) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Basal Insulin (Long-Acting Insulin) Revenue 2017-2028 (US$ Million)
Figure 16. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2022)
Figure 18. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2023-2028)
Figure 19. North America Basal Insulin (Long-Acting Insulin) Sales YoY (2017-2028) & (K Units)
Figure 20. North America Basal Insulin (Long-Acting Insulin) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Basal Insulin (Long-Acting Insulin) Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Basal Insulin (Long-Acting Insulin) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Basal Insulin (Long-Acting Insulin) Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Basal Insulin (Long-Acting Insulin) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Basal Insulin (Long-Acting Insulin) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Basal Insulin (Long-Acting Insulin) in the World: Market Share by Basal Insulin (Long-Acting Insulin) Revenue in 2021
Figure 31. Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
Figure 33. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)
Figure 34. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 35. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)
Figure 36. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
Figure 37. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)
Figure 38. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 39. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)
Figure 40. North America Basal Insulin (Long-Acting Insulin) Sales Share by Country (2017-2028)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs